Skip to main content

Free billing screening

Get screening →
Resource

Medical Billing Denial Benchmarks 2026

By · Published

Published denial rates measure different things on different populations: a measured rate, a managerial target, or a synthetic example. MGMA puts practice first-submission denials at 7% to 8%; hospital and payer-side rates are not comparable to that. Each figure below carries its population, denominator and source, read on 1 October 2026.

Quick Answer

What Is a Normal First-Pass Denial Rate?

A first-pass denial rate is the share of claims, or of claim dollars, a payer denies on first adjudication; sources count it differently. MGMA benchmarking puts first-submission denials at 7% to 8% across the past four years (30 July 2026); AAFP guidance calls 5% to 10% average and below 5% more desirable. HFMA's standards pages publish formulas, not a target. Hospital and payer-side rates measure different populations.

  • MGMA: first-submission denials at 7% to 8% across the past four years (30 July 2026); 8% in its 2023 DataDive data, the same as 2019
  • AAFP guidance, computed on denied dollars over submitted dollars with no sample published: 5% to 10% average, below 5% more desirable
  • HFMA: two denial-rate definitions (MAP Key AR-5 and the Claim Integrity Task Force initial denial rate), no target values
  • KFF, payer side: 19% of in-network marketplace claims ultimately denied in 2024; final status only, so not a first-pass rate

How Is a First-Pass Denial Rate Defined? HFMA's Two Definitions

In our reading, what the trade calls a first-pass denial rate corresponds most closely to the initial denial rate that HFMA's Claim Integrity Task Force standardizes, and HFMA's MAP Keys define a second, different remittance denial rate. Both pages publish definitions only: neither carries a target value, and the MAP Keys page says its definitions are the basis for data reported by subscribers of HFMA's MAP App benchmarking tool.

ElementMAP Key AR-5: remittance denial rateClaim Integrity Task Force: initial denial rate
FormulaClaims denied ÷ claims remittedBy volume: initial denial claims ÷ claims submitted. By dollars: initial denial gross charges ÷ submitted gross charges
Which denials count"Actionable denials" only, those that may be addressed and corrected within the organization: remittances carrying a denial code, including initial denials and later appeal denials, and zero-pay or partial-pay remittances with a denial indicatorOnly the first denial on each claim; if a claim has several, the first chronological denial is selected
ExcludedPlan-exclusion denials (group code PR), patient-responsibility denials, RAC recoupments, duplicate-claim denials, shadow or encounter claimsRebills: bill type XX7 on a UB-04, an R in Box 22 on a CMS-1500
DenominatorClaims remitted in the month, counted at claim level; line-item counts are not usedClaims submitted; for the volume formula, the average of the 3-month period before the start of the reporting month
Read atHFMA MAP KeysHFMA Claim Integrity Task Force

The two are built differently, so they can give different answers on the same month of claims, and a rate is only comparable when its definition travels with it. The Task Force adds that line-level reporting is the best practice for analysis and defines that version in its appendix. Two other published figures differ in kind again: AAFP's band is computed on denied dollars, and KFF's 19% counts final adjudication status only, so a claim denied and later paid is not counted. The sample analysis below counts first-pass payer denials against claims that reached adjudication, which is closer to the AR-5 denominator than to the Task Force's. To run your own number on a fixed definition use the denial rate calculator; claims returned before adjudication are covered in rejections versus denials.

Our reasoning, not a published finding: if rejections rise, fewer claims reach adjudication, so a denial rate counted on adjudicated claims can fall while collections fall; track rejections and denials side by side.

The Evidence Ledger: Every Figure on This Page

This is the whole ledger of denial-rate, appeal and cost figures. Each row states the figure exactly as its source states it, the population it was measured on, the denominator, whether it is a measurement, a survey response or a target, and where we read it. Other figures are labelled where they appear: the synthetic example, the prior authorization rule dates and poll, and the list of figures we could not source. The only free specialty-group figures we found are MGMA's 2019 and 2020 first-submission rates, listed in the ledger; we found no current specialty rate, so none is printed as a benchmark. The denial drivers that can be traced to CMS policy and federal regulation are mapped on denial rates by specialty, and service-level detail sits on the cardiology, orthopedic, mental health and physical therapy billing pages.

FigurePopulationDenominator / basisKindSource (read 1 Oct 2026)
"MGMA benchmarking puts first-submission denials at 7% to 8% across the past four years"; MGMA adds that its 2025 Financials and Operations data report "suggests practices can push the rate below 5% with targeted process fixes"Physician practice: practices in MGMA benchmarking; cohort not stated in the articleNot stated: MGMA gives no formula, sample or specialty mix with this figure, and the "below 5%" is MGMA's suggestion about process fixes, not a published targetMeasuredMGMA Stat, 30 July 2026
"a single-specialty aggregate rate of 8% for claims denied on first submission"Physician practiceSingle-specialty aggregate, 2023 MGMA DataDive Practice Operations data set. MGMA notes the same 8% was documented in 2019 and states no formula, so whether it counts claims or dollars is not publishedMeasuredMGMA
"The percent of claims denied on first submission for primary care specialties dropped from 8% in 2019 to 4% in 2020"; nonsurgical specialties "from 7% in 2019 to 3% in 2020"; surgical specialties "from 8% in 2019 to 4.16% in 2020"Physician practices by specialty group (primary care, nonsurgical, surgical), per MGMA's "2021 and 2020 MGMA DataDive Practice Operations benchmarks"; 2019 and 2020 data (2020 the first pandemic year), about six years oldPercent of claims denied on first submission; sample not statedMeasuredMGMA Stat, 11 November 2021
"A 5% to 10% denial rate is the industry average; keeping the denial rate below 5% is more desirable"Practices (AAFP's page is framed for family medicine; no population stated)Dollar amount of claims denied ÷ dollar amount of claims submitted, per AAFP's own calculation. Population, sample and data year: not published; AAFP gives it as practice-management guidanceTargetAAFP
"The industry average denial rate is between 5% and 10%, while less than 5% is optimal"Repeated on hfma.org in an article marked "Sponsored by Conifer Health Solutions", which links AAFP material for the denial rateDollars, per the same article: "divide the total dollar amount of denied claims by the total dollar amount of claims submitted in the same timeframe"Relayed targetHFMA, sponsored article
"their rate of first-pass denials is higher: 13.6% versus 10.9%, based on survey responses", with 12.5% where attention to prevention and management is equalHealthcare finance professionals responding to a Waystar/HFMA survey, February-March 2023; sample size and provider type not stated in the articleRespondents' own first-pass denial rates, split by whether the organization puts more resources into denial management (13.6%) or prevention (10.9%); no formula givenSurvey (self-reported)HFMA, Waystar-sponsored article; HFMA says it "does not endorse the published material or warrant or guarantee its accuracy"
"denial rates remained consistent at nearly 15 percent, according to survey data, they ranged as high as 49 percent in certain instances"Hospital: Premier member hospitals and health systems; voluntary survey of 280 hospitals in 23 states on 2023 claims (release of 24 February 2025); the release's opening sentence also names post-acute care providers, while its methodology lists member hospitals and health systemsAverages weighted by acute bed capacity. Premier publishes no formula; its cost calculation applies 0.15 as "the average denial rate identified by the survey"Survey (self-reported)Premier
"approximately 70 percent of denials are overturned and paid", a general statement in the release; average cost incurred fighting a denial $57.23 per claim in 2023, against $43.84 the prior year (from the survey)The 70% sentence names no population; the cost figures are Hospital: the same Premier surveyDenied claims. Premier's methodology applies 68.6 percent as ultimately paid when costing them; cost per claim is the survey's "average cost incurred"Stated in the release (70%); survey, self-reported (cost)Premier
"denied 19% of in-network claims in 2024"; out-of-network 37%; insurer-level in-network range "3% to 36%"Payer side: HealthCare.gov qualified health plans onlyIn-network claims received: 451 million of about 496 million total claims, with approximately 85 million "ultimately denied". Final adjudication status only: KFF states "Claims that were initially denied, then subsequently resubmitted and paid, are not included as denied claims in the denial rate." Not a first-pass rateMeasuredKFF
For in-network claims processed by HealthCare.gov parent companies that received more than 5 million claims in 2024, the average in-network denial rate was 19%, "ranging from 8% (Elevance Health) to 25% (Oscar Health)"Payer side: HealthCare.gov qualified health plans, large parent companies onlyIn-network claims received by each parent company; final adjudication status only, as in the row above. Not a first-pass rate and not a practice-level rateMeasuredKFF
In-network denial reasons: "Other" [reason not listed] 36%; administrative reasons 25%; excluded service 13%; lack of prior authorization or referral 9%; medical necessity 5%Payer side: HealthCare.gov qualified health plans; KFF describes the reason data as limitedShares of reported denial reasons, not of claims: a claim can carry more than one reason, and the data do not link reasons to the services deniedMeasuredKFF
Of denied in-network marketplace claims, consumers appealed "at least 262,982 – an appeal rate of less than 1%"; insurers "upheld 165,863 (66%) denials on appeal"Payer side, marketplaceDenied in-network claims; appeals receivedMeasuredKFF
Medicare Advantage insurers "fully or partially denied 4.1 million prior authorization requests" — 7.7% of all requests, against 6.4% in 2023Medicare Advantage, payer sidePrior authorization requests determinedMeasuredKFF
Medicare Advantage insurer-level prior authorization denial rates: "from 4.2% of prior authorization requests for Elevance Health plans to 12.8% of prior authorization requests for UnitedHealth Group plans"Medicare Advantage, payer side; large insurersPrior authorization requests determined in 2024; the overall rate includes requests both fully and partially denied. Not a claim denial rate and not a practice-level rateMeasuredKFF
"Just 11.5% of denied prior authorization requests were appealed" in 2024, and 80.7% of appealed denials were partially or fully overturnedMedicare Advantage, payer sideDenied PA requests; appealed denialsMeasuredKFF
"among the prior authorization requests that MAOs denied, 13 percent met Medicare coverage rules"; "among the payment requests that MAOs denied, 18 percent of the requests met Medicare coverage rules and MAO billing rules"Government audit of Medicare Advantage organizationsDenials sampled — not claims submitted. Stratified random sample of 250 prior authorization denials and 250 payment denials from 15 of the largest MAOs, 1-7 June 2019MeasuredOIG

How to read this table without making the standard mistake. Most rows are not comparable to each other. The Kind column says how much weight a row carries: a measurement, a survey response self-reported by the people surveyed, a target stated as guidance, or a target relayed from another body. The hospital rows describe institutional claims; the physician-practice rows describe professional claims; the payer-side rows describe what an insurer did with everything it received, across every provider type. A practice that compares its own denial rate to the 19% marketplace figure, or to a hospital figure, will reach a wrong conclusion in whichever direction the mismatch runs. Compare like to like, or compare to your own prior period, which is usually the more useful comparison anyway.

What HFMA and MGMA do and do not publish. HFMA's standards pages, the MAP Keys and the Claim Integrity Task Force report, carry definitions and formulas, not target values. The 5% to 10% band does appear on hfma.org, but inside an article marked "Sponsored by Conifer Health Solutions" that links AAFP material for it and credits Becker's ASC for a 98% clean claims aim; the same band is on AAFP's own page, which publishes no clean-claim figure. The first-pass denial rates we found on hfma.org are survey responses in a Waystar-sponsored 2023 article, and HFMA says it does not endorse or warrant that material. We found no HFMA top-quartile denial rate. MGMA's DataDive percentiles and quartile tools are presented through a product demo, and the MGMA Stat articles we read publish first-submission denial rates only in the three MGMA rows of the ledger, none with a stated sample. We state those blanks rather than filling them.

Is Every CARC Adjustment a Denial?

We have no national frequency ranking of CARC codes to give you. The widely repeated "about 20 CARC codes account for roughly 80 percent of denial volume" is not traceable to a published study with a stated population and denominator, we could not source one, and the X12 code list carries start, stop and modification dates but no frequency data. Inventing a distribution to make a page look authoritative is the exact failure this page exists to avoid.

What can be said is narrower: not every CARC line on a remittance is a denial. X12's FAQ defines "adjusted" as meaning the charge amount differs from the payment amount, and lists denial, zero payment, partial payment, reduced payment, penalty applied, additional payment and supplemental payment as examples. The deductible, coinsurance and copay lines (CARC 1, 2 and 3) and the contractual write-down (CARC 45) are routine adjustments, not denials, so a denial rate computed by counting every CARC line is inflated by routine write-offs.

The operational implication is the one that runs through this whole page: classify at ingestion — contractual adjustment, patient cost-sharing, or denial — then categorise only the third group and route each category to the team that owns the prevention step. Code meanings, group codes and remark codes are on CARC and RARC codes explained and in the denial codes database; the code descriptions themselves are X12's and are read from the X12 list.

Sample Denial Analysis (Illustrative)

This is an illustrative example demonstrating MedPrecision's reporting methodology. It is not presented as the result of an actual client engagement. Every practice-level figure below is synthetic. No patient, practice, or payer data appears anywhere on this page. Where a public benchmark comparator is shown, it is real and cited.

Example Practice A — the same illustrative practice used across all of our sample deliverables, so the artifacts can be read end to end: a four-physician, two-APP family medicine group in Ohio, roughly 2,050 encounters and $412,000 in gross charges per month. Reporting period: June 2026.

The benchmarks above describe the industry. This is what the same analysis looks like applied to a single practice for a single month — the artifact, not the average.

Denials by CARC code

127 of the 1,940 claims that reached adjudication were denied on first pass — a 6.5% payer denial rate. Each row carries the disposition decision, because a denial count without a disposition is a statistic rather than a worklist.

CARCReasonClaims% of denialsCharges deniedDisposition
CO-16Missing or incomplete information2822.0%$5,880Correct and resubmit
CO-197No prior authorization on file1915.0%$7,410Appeal with documentation
CO-97Bundled into another service1612.6%$2,720Appeal with documentation
CO-4Modifier does not fit the procedure code1411.0%$3,150Correct and resubmit
CO-11Diagnosis does not fit the procedure129.4%$2,640Correct and resubmit
CO-27Service after coverage ended118.7%$2,530Re-route to correct payer or patient
OA-18Same claim or line already received97.1%$1,845Correct and resubmit
CO-22Another payer may be primary (COB)86.3%$1,920Re-route to correct payer or patient
CO-29Filed after the payer's deadline53.9%$1,275Write off with reason code
OtherRemaining codes53.9%$1,010Write off with reason code
Total127100%$30,380

Percentages are rounded to one decimal, so the column sums to 99.9% rather than 100%.

Disposition summary — what actually happens to the money

DispositionClaimsChargesShare of denied dollars
Correct and resubmit63$13,51544.5%
Appeal with documentation35$10,13033.3%
Re-route to correct payer or patient19$4,45014.6%
Write off with reason code10$2,2857.5%
Total127$30,380100%

We publish the write-off line. $2,285 in this month is not coming back, and 5 of those claims died on timely filing — a process failure, not a payer decision. A denial analysis that reports only recoverable dollars is a sales document.

How this month compares to public data

  • The practice's 6.5% denial rate above is a claim count measured on claims that reached adjudication. AAFP's 5–10% guidance is computed on a different basis — denied claim dollars over submitted claim dollars — so read it as an order-of-magnitude sanity check here, not a like-for-like comparison. The definition matters inside the example too. On HFMA's AR-5 definition, which excludes duplicate-claim denials, and treating the 1,940 adjudicated claims as the claims remitted, the same month scores 6.1% (118 of 1,940: the 127 denials less the 9 duplicate-claim denials). A first-pass failure view that also counts the 74 clearinghouse rejections, against all 2,014 claims submitted, gives 10.0% (201 of 2,014); it is a different metric because a rejection never reaches adjudication. One set of claims, three rates, which is why the definition has to travel with the number.
  • For context on the payer side rather than the practice side: KFF found HealthCare.gov insurers denied 19% of in-network claims in 2024, with individual insurer rates ranging from 3% to 36%. That is a different denominator — marketplace plans, all claim types — and should not be read as a practice target.
  • KFF also reports that consumers appealed at least 262,982 of the roughly 85 million denied in-network HealthCare.gov claims in 2024 (less than 1%), and that insurers upheld 66% of the appeals they received. Those are patient appeals on marketplace plans, not practice appeals, so they say nothing about how often practices appeal; measure your own appeal rate and overturn rate by payer.
  • On the prior-authorization side, KFF found Medicare Advantage insurers denied 4.1 million requests (7.7%) in 2024, only 11.5% of those denials were appealed — and 80.7% of appealed denials were partially or fully overturned. Those are appeals of denied authorization requests on Medicare Advantage, not of claims denied for absent authorization, so they do not give the odds for the 19 CO-197 claims above. Track your own overturn rate on these before deciding how much effort to put into them.

The root-cause reading

Grouping by CARC answers what was denied. Grouping by originating step answers why, and only the second one generates a fix:

  1. Front-end capture — 47 claims ($10,330). CO-16, CO-27 and CO-22 all originate at registration and eligibility verification, not in billing. This is the largest single root cause.
  2. Coding and modifiers — 42 claims ($8,510). CO-4, CO-11 and CO-97 point at coding and scrubber-rule gaps.
  3. Authorization — 19 claims ($7,410). The highest dollar-per-claim group at $390, handled by prior authorization.
  4. Process failure — 5 claims ($1,275). CO-29 timely filing. Unrecoverable, and the only category that is entirely self-inflicted.

The remaining 14 denials ($2,855), nine duplicate-claim denials and five coded Other, sit outside these four groups.

The single highest-value action is not the highest dollar-per-claim group — it is the front-end capture group, because those 47 denials recur every month until the registration workflow changes.

Prior Authorization: What Is Published, and What Changes in 2026

Prior authorization is a denial category with published data of its own, because Medicare Advantage reporting and federal audit work have produced figures with stated populations and samples. It is also the category where federal rules are actively changing what payers must do.

What is measured. Two sources, both payer-side or audit-side rather than provider-side:

  • KFF's analysis of CMS data found that Medicare Advantage insurers fully or partially denied 4.1 million prior authorization requests in 2024, a somewhat larger share — 7.7% — of all requests than in 2023, when the figure was 6.4%. Of denied requests, just 11.5% were appealed, and 80.7% of appealed denials were partially or fully overturned.
  • OIG reviewed a stratified random sample of 250 prior authorization denials and 250 payment denials issued by 15 of the largest Medicare Advantage organizations during 1-7 June 2019, and found that 13 percent of the denied prior authorization requests met Medicare coverage rules and 18 percent of the denied payment requests met Medicare coverage rules and the organizations' own billing rules. Note the denominator: denials sampled, not requests submitted.

What changes in 2026 and 2027. The CMS Interoperability and Prior Authorization Final Rule (CMS-0057-F) applies to Medicare Advantage organizations, state Medicaid and CHIP fee-for-service programmes, Medicaid managed care plans, CHIP managed care entities, and Qualified Health Plan issuers on the federally facilitated exchanges. CMS states the rule requires prior authorization decisions within 72 hours for expedited requests and seven calendar days for standard requests, with those timeframes beginning to apply from 1 January 2026 for impacted payers other than exchange QHP issuers. Beginning in 2026, payers must also give a specific reason for a denied prior authorization decision, which CMS says is intended to improve providers' ability to resubmit the request; the rule does not apply to drug decisions. Payers must publicly report certain prior authorization metrics annually on their websites, and the initial set was due by 31 March 2026. The API requirements generally begin on 1 January 2027, with exact dates varying by payer type.

Whether practices are seeing the shorter clocks is a separate question. In a 1 September 2026 MGMA Stat poll, 44% of medical group leaders said payer prior authorization turnaround became slower in 2026 than in 2025, 40% said about the same, 7% said faster and 9% were unsure (178 applicable responses; self-reported, not a measured turnaround). MGMA's reading is that a shorter regulatory decision deadline does not necessarily mean the whole authorization process takes less time for the practice. MGMA describes the metrics payers must now post as aggregate approval and denial rates, approvals after appeal and average time between submission and decision; they are a payer-specific source to read alongside your own data, so build an annual check of those postings into your payer-management calendar.

On the provider side, the corresponding adjudication code is CARC 197, authorization absent, and its prevention step happens at scheduling rather than at billing.

Targets, and What Actually Separates Practices

There is no published top-quartile denial rate for physician practices that we could verify, so this page does not print one. The free sources give one current measurement and one managerial anchor. MGMA benchmarking puts first-submission denials at 7% to 8% across the past four years (30 July 2026) and suggests targeted process fixes can push the rate below 5%, which is a suggestion, not a published target. AAFP states, as practice-management guidance with no population, sample or data year attached, that a 5% to 10% denial rate is the industry average and that below 5% is more desirable; it is computed on denied dollars over submitted dollars rather than on a claim count, and the difference matters when you put it in a board pack. For clean claim rate and first-pass resolution rate (also called first-pass yield), see the four metrics people call clean claim rate; AAFP publishes no clean-claim-rate figure. AAFP's same page gives two further targets, again as guidance with no sample: an adjusted collection rate of at least 95% (average 95% to 99%) and days in A/R below 50, with 30 to 40 preferable.

What we can describe without a number is the set of operational disciplines that distinguish practices whose denial rate falls from practices whose denial rate is merely reported. These are stated as practice, not as evidence of an outcome:

  1. Pre-submission scrubbing with current edit tables. Refresh NCCI Procedure-to-Procedure edits, MUE limits and payer-specific rules on a calendar. Stale tables produce both false-positive scrubs and missed denials.
  2. Real-time eligibility verification before service. 270/271 transactions confirming coverage, cost-sharing, deductible accumulation and behavioral-health carve-out routing. Eligibility denials originate at registration, so the fix belongs there.
  3. Authorization tracking integrated with scheduling. No service performed without a confirmed authorization where payer policy requires one.
  4. A denial worklist categorised at ingestion, with payer-specific routing — and with contractual adjustments and patient cost-sharing separated out before categorisation, so the worklist is denials rather than everything.
  5. A same-week feedback loop to the front-end teams. Eligibility items to the front desk, authorization items to the authorization team, bundling items to coding. Without the loop, the same denials recur.
  6. Modifier discipline created at the encounter, not at appeal. Documentation supporting a distinct-service or unrelated-E/M modifier has to exist before the claim goes out; it is hard to retrofit once the claim has denied.
  7. A timely-filing aging report run daily, with a same-day charge-entry service level behind it.

On the economics of appealing. The only cost-of-appeal figure we could verify is Premier's, and its population is hospitals and health systems, not physician practices: an average cost incurred fighting a denial of $57.23 per claim on 2023 claims, against $43.84 the year before. Do not import that per-claim cost into a physician-practice model; compute your own from biller minutes per appeal and your loaded rate.

Teams that would rather hand the worklist to a specialist can see how that work is scoped on our denial management services page. For the prevention disciplines in more depth, see how to reduce claim denials. Read the payer's own current policy before building a rule; we do not publish unsourced payer-by-payer denial rules.

Methodology, Sources, and What We Removed

The rule this page follows. Every published figure carries a population, a denominator and a link to a source we re-read on 1 October 2026, or it is labelled synthetic, or it is in the table below as a figure we could not source. Where a figure could not be tied to a retrievable source with a stated population, we removed it rather than softening it into a range, because a softened unsourced figure is still an unsourced figure, and it is harder for a reader to catch. A "no source found" finding dated 17 September 2026 was not re-searched on 1 October 2026.

The figures we removed, and what the primary source says. Each row pairs a widely quoted figure with the correction beside it, so a reader who remembers seeing the figure here knows it was withdrawn rather than relocated:

Widely quoted figureAttributed toWhat the primary source says
A 9-to-12 percent industry first-pass denial rangeMGMA DataDive and HFMAMGMA's own 30 July 2026 article puts first-submission denials at 7% to 8% across the past four years. HFMA's MAP Keys and Task Force pages publish no such range
An HFMA top-quartile denial target below 5 percentHFMAHFMA's MAP Keys and Task Force pages publish no top-quartile value. MGMA says only that its 2025 Financials and Operations data report "suggests practices can push the rate below 5% with targeted process fixes"
A clean-claim target of 95 to 98 percentHFMAHFMA's MAP Key CL-1 defines the clean claim rate and publishes no target value. A 98% clean claims aim appears on hfma.org in an article marked "Sponsored by Conifer Health Solutions", credited there to Becker's ASC
An MGMA median net collection rate near 93 percent and an HFMA top-quartile target of 96 percent or aboveMGMA and HFMANo free primary source found (17 September 2026 review)
An MGMA median near 40 days in A/R and an HFMA best-practice target under 35 daysMGMA and HFMANo free primary source found (17 September 2026 review). AAFP's guidance is on days in A/R formula and benchmark
About 20 CARC codes account for about 80 percent of denial volumeMGMA, HFMA and AAPCWe found no published CARC frequency distribution (17 September 2026 review), and the X12 code list publishes no frequency data
About 65 percent of denied claims are never appealedHFMANo source found (17 September 2026 review). The free appeal rates are payer-side: KFF found fewer than 1% of denied marketplace claims were appealed, and KFF 11.5% of denied Medicare Advantage prior authorization requests
An appeal cost of roughly $25 to $118 per claimHFMA and Advisory BoardNo source found (17 September 2026 review). Premier's $57.23 is a hospital survey average on 2023 claims
Appeal overturn rates of 40-50 percent average and 65-75 percent best practice, plus category-specific rangesIndustry guidanceNone traceable to a population (17 September 2026 review)
Best-in-class multi-specialty groups run 3-4 percentIndustry guidanceNo source found for a best-in-class figure (17 September 2026 review). MGMA's 2020 first-submission rates for specialty groups were 3% to 4.16%, a pandemic year, sample not stated
A Medicare Advantage denial-rate range of about 5 percent to over 18 percent by insurerKFFKFF's Medicare Advantage brief reports prior authorization determinations (7.7% denied in 2024), not a claim denial range; by insurer, its prior authorization denial rates run from 4.2% to 12.8% of requests
Payer audit thresholds: percentages of visits, session counts, unit caps and biopsy countsUnitedHealthcare, Aetna, Cigna and BCBS plansNo retrievable payer policy document found (17 September 2026 review)
A physician-survey figure on prior-authorization-related serious adverse eventsAn annual physician surveyThe underlying report could not be retrieved to verify the figure or its sample (17 September 2026 review)

The one comparison that is always valid. Your own prior period, on a fixed definition. Every external figure on this page carries a population that is probably not yours; your last quarter does not.

Free Billing Screening · No obligation

Benchmark Your Denials Against Your Own Data

Get a free billing screening — a preliminary review of a permitted 12-month practice-management export, with a short written memo within five business days. Chart-based audit work is scoped separately.

Prefer to talk? Book a 15-minute call

A free screening reviews a permitted 12-month practice-management export and provides a short written memo within five business days after receipt. It includes no chart review, coding opinion or extrapolated recovery figure. Chart-based audits are separately scoped and quoted.

Solo provider or group practice?

Practice details only · No obligation to continue · We reply within 1 business day

Common Questions

Common questions about medical billing denial benchmarks 2026: the evidence ledger.

Get a Free Billing Screening

Our billing specialists can walk you through this and more.

Request a Free Screening

What is a good first-pass denial rate?

MGMA benchmarking puts first-submission denials at 7% to 8% across the past four years (30 July 2026) and suggests targeted process fixes can push the rate below 5%. AAFP calls 5% to 10% the industry average and below 5% more desirable, computed on denied dollars over submitted dollars with no sample published, so it is a target rather than a measurement. Compare your own rate on a fixed definition with the denial rate calculator.

What is the HFMA denial rate benchmark?

HFMA publishes definitions, not a benchmark value. MAP Key AR-5 defines the remittance denial rate and the Claim Integrity Task Force defines the initial denial rate; neither carries a target. The 5% to 10% band on hfma.org sits in an article sponsored by Conifer Health Solutions that links AAFP material. hfma.org also carries first-pass denial rates of 13.6%, 12.5% and 10.9%, depending on how organizations split resources, from a Waystar-sponsored 2023 survey article that HFMA says it does not endorse or warrant.

What is the hospital claim denial rate benchmark?

Hospitals are a different population from physician practices. Premier reports an average denial rate of nearly 15 percent on 2023 claims from its member hospitals, weighted by acute bed capacity, with rates as high as 49 percent in certain instances; the survey was voluntary and self-reported. Vendor analyses of hospital and mixed hospital-physician claim data are listed with their caveats in the benchmarks report. None of these is a physician-practice benchmark.

What is the average claim denial rate in the United States?

There is no single national figure, because published rates measure different populations. For practices, MGMA puts first-submission denials at 7% to 8% across the past four years (30 July 2026). For hospitals, Premier's survey says nearly 15 percent. On the payer side, KFF found HealthCare.gov insurers denied 19% of in-network claims in 2024, from 3% to 36% by insurer, but it counts final adjudication status only, so a claim denied and later paid is not counted. That is a final-status rate, not a first-pass rate.

What is the most common reason for claim denial?

We could not find a free source that ranks denial reasons for physician practices, so we print no ranking. The breakdown we cite here is payer-side: in KFF's 2024 marketplace data, administrative reasons were 25% of reported denial reasons, excluded services 13%, missing prior authorization or referral 9% and medical necessity 5%, with 36% listed as other. One claim can carry several reasons. Rank your own remittances by dollars at risk, with cost-sharing and contractual adjustments classified out first; code meanings are on CARC and RARC codes explained.

What percentage of denied claims are appealed, and how many are overturned?

We could not source a physician-practice figure. On the payer side, KFF found consumers appealed at least 262,982 denied in-network marketplace claims in 2024, less than 1% of denials, and insurers upheld 66% of the appeals they received; for Medicare Advantage prior authorization, 11.5% of denials were appealed and 80.7% of appealed denials were partially or fully overturned. Premier's release states that approximately 70 percent of denials are overturned and paid, as a general statement (its methodology applies 68.6 percent). Measure your own by payer and denial category.

How much does it cost to fight a denied claim?

Premier's survey of its member hospitals puts the average cost incurred fighting a denial at $57.23 per claim on 2023 claims, up from $43.84 the year before. It is a hospital figure and should not be imported into a practice model. Compute your own from biller minutes per appeal multiplied by your loaded hourly rate.

How does denial rate vary by specialty?

The only free specialty-group figures we found are in a November 2021 MGMA Stat article: first-submission denial rates of 8% in 2019 and 4% in 2020 for primary care, 7% and 3% for nonsurgical specialties, and 8% and 4.16% for surgical specialties. They cover 2019 and 2020, are about six years old and were published without a sample, so this page prints no current specialty rate. The denial drivers that can be traced to CMS policy and federal regulation, specialty by specialty, are mapped on denial rates by specialty. For your own practice, group your remittances by specialty and payer and compare against your prior period.

Free billing screening

Benchmark Your Denials Against Your Own Data

Talk to a billing specialist and start with a free billing screening of a permitted 12-month practice-management export.

A free screening reviews a permitted 12-month practice-management export and provides a short written memo within five business days after receipt. It includes no chart review, coding opinion or extrapolated recovery figure. Chart-based audits are separately scoped and quoted.

  • No obligation to continue
  • Practice details only
  • Reply within 1 business day
Call us Free screening